Sort
261,768 grants matching “gene therapy”
Polypeptide Microbicides Targeting CCR5
$1,368,411University Of Md Biotechnology Institute · P01 · FY2003 · AI
Integrated Systems Biology Approach to Diabetic Microvascular Complications
$1,368,284Eva L Feldman · University Of Michigan At Ann Arbor · R24 · FY2019 · DK
HIV persistence in vivo
$1,368,258Eli Boritz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Phase 1b/2a Trial of QBS-72S for the Treatment of Newly Diagnosed Glioblastoma Multiforme in Patients with Unmethylated MGMT Promoters
$1,368,236Gordon M Ringold · Quadriga Biosciences, Inc. · R44 · FY2021 · CA
Role of Inducible Bronchus Associated Lymphoid Tissue in Latent Tuberculosis
$1,368,144Shabaana A. Khader · University Of Chicago · R01 · FY2024 · AI
Role of Inducible Bronchus Associated Lymphoid Tissue in Latent Tuberculosis
$1,368,144Shabaana A. Khader · University Of Chicago · R01 · FY2025 · AI
A first in human clinical study of TT101, a synthetic immunomodulatory material to build new functional tissue over exposed bone as a one time treatment for diabetic limb preservation patients
$1,368,090Stephanie Deshayes · Tempo Therapeutics, Inc. · R44 · FY2021 · DK
Molecular Therapeutics for Epithelial Disorders
$1,367,983Stanford University · P01 · FY2002 · AR
Improving the Outcome of Patients with Chronic Myeloid Leukemia Through Medi
$1,367,891Jorge E Cortes · University Of Tx Md Anderson Can Ctr · P01 · FY2012 · CA
Lambda Genetic Networks and Lambda Red-Mediated Recombination
$1,367,570Donald Court · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Cell Survival and Cancer
$1,367,486Thomas Jefferson University · P01 · FY2005 · CA
ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM FOR HIV/AIDS
$1,367,405Miriam Hospital · U01 · FY2004 · AI
Leber's Hereditary Optic Neuropathy: Gene Therapy Clinical Trial
$1,367,380John R Guy · University Of Miami School Of Medicine · U10 · FY2016 · EY
Therapy for NF1-Related Tumors and other Genetic Tumor Predisposition Syndromes
$1,367,242Brigitte Widemann · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Translational studies for identifying and targeting novel pathways in systemic sclerosis pathogenesis
$1,367,116Robert A Lafyatis · University Of Pittsburgh At Pittsburgh · P50 · FY2019 · AR
The Pathogenesis, Diagnosis, and Treatment of Systemic Mast Cell Disorders
$1,366,986Hirsh D Komarow · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Immune Function and the Progression to Type 1 Diabetes
$1,366,867Mark A Atkinson · University Of Florida · P01 · FY2018 · AI
Novel Therapeutics for Class B Protozoa
$1,366,784Sharon L Reed · University Of California, San Diego · U01 · FY2011 · AI
NF-kB Inhibition Therapy for Duchenne Muscular Dystrophy
$1,366,658Denis C Guttridge · Ohio State University · U01 · FY2011 · NS
NF-kappaBeta Therapy for Duchenne Muscular Dystrophy
$1,366,658Denis C Guttridge · Ohio State University · U01 · FY2011 · NS
Enzyme replacement therapy for GM1 gangliosidosis lysosomal rare disease
$1,366,586David Radin · Biostrategies, Lc · R44 · FY2017 · NS
NF-kB Inhibition Therapy for Duchenne Muscular Dystrophy
$1,366,577Denis C Guttridge · Ohio State University · U01 · FY2010 · NS
Molecular Analysis Of Retroviral Genes And Their Products
$1,366,460Klaus Strebel · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
The LUCINDA Trial
$1,366,388Tracy A. Butler · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · AG
H. pylori-induced Inflammation and Gastric Cancer
$1,366,185Richard M Peek · Vanderbilt University Medical Center · P01 · FY2021 · CA